Severe Sepsis
2 competing products in clinical development for Severe Sepsis.
Pipeline by Phase
Phase 21
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| eritoran tetrasodium + Placebo | Eisai | Phase 3 | Completed | 40 |
| Drotrecogin alfa (activated) | Eli Lilly | Phase 2 | Completed | 35 |